Nancy Wisnewski Biography and Net Worth

COO of Heska


Nancy Wisnewski, Ph.D. was appointed Executive Vice President, Chief Operating Officer in August 2019. She previously served as Executive Vice President, Diagnostic Operations and Product Development from September 2016 to August 2019, as Executive Vice President, Product Development and Customer Service from April 2011 to September 2016 and as Vice President, Product Development and Technical Customer Service from December 2006 to April 2011. From January 2006 to November 2006, Dr. Wisnewski was Vice President, Research and Development. Dr. Wisnewski held various positions in Heska's Research and Development organization between 1993 and 2005. She holds a Ph.D. in Parasitology/Biochemistry from the University of Notre Dame and a BS in Biology from Lafayette College.

What is Nancy Wisnewski's net worth?

The estimated net worth of Nancy Wisnewski is at least $6.66 million as of August 18th, 2021. Dr. Wisnewski owns 55,499 shares of Heska stock worth more than $6,659,325 as of November 12th. This net worth approximation does not reflect any other assets that Dr. Wisnewski may own. Learn More about Nancy Wisnewski's net worth.

How old is Nancy Wisnewski?

Dr. Wisnewski is currently 60 years old. There are 6 older executives and no younger executives at Heska. Learn More on Nancy Wisnewski's age.

How do I contact Nancy Wisnewski?

The corporate mailing address for Dr. Wisnewski and other Heska executives is 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO, 80538. Heska can also be reached via phone at (970) 493-7272 and via email at [email protected]. Learn More on Nancy Wisnewski's contact information.

Has Nancy Wisnewski been buying or selling shares of Heska?

Nancy Wisnewski has not been actively trading shares of Heska during the last ninety days. Most recently, Nancy Wisnewski sold 1,000 shares of the business's stock in a transaction on Wednesday, August 18th. The shares were sold at an average price of $270.33, for a transaction totalling $270,330.00. Following the completion of the sale, the chief operating officer now directly owns 55,499 shares of the company's stock, valued at $15,003,044.67. Learn More on Nancy Wisnewski's trading history.

Who are Heska's active insiders?

Heska's insider roster includes Catherine Grassman (CFO), Sharon Larson (Director), Kevin Wilson (CEO), and Nancy Wisnewski (COO). Learn More on Heska's active insiders.

Nancy Wisnewski Insider Trading History at Heska

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/18/2021Sell1,000$270.33$270,330.0055,499View SEC Filing Icon  
6/4/2021Sell5,000$197.87$989,350.0059,998View SEC Filing Icon  
11/18/2020Sell1,500$127.50$191,250.00
8/31/2020Sell1,050$103.87$109,063.5049,124View SEC Filing Icon  
6/8/2018Sell750$106.50$79,875.0034,873View SEC Filing Icon  
6/1/2018Sell2,250$108.20$243,450.0037,123View SEC Filing Icon  
5/30/2018Sell2,500$104.14$260,350.0039,498View SEC Filing Icon  
8/31/2017Sell825$102.21$84,323.2538,114View SEC Filing Icon  
5/24/2017Sell250$100.17$25,042.5038,901View SEC Filing Icon  
See Full Table

Nancy Wisnewski Buying and Selling Activity at Heska

This chart shows Nancy Wisnewski's buying and selling at Heska by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Heska Company Overview

Heska logo
Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.
Read More

Today's Range

Now: $119.99
Low: $119.99
High: $119.99

50 Day Range

MA: $119.09
Low: $115.55
High: $119.99

2 Week Range

Now: $119.99
Low: $57.83
High: $120.03

Volume

N/A

Average Volume

241,932 shs

Market Capitalization

$1.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58